NCT02482467 (KYSTOV) is a NA clinical trial of Hormonal analysis, pelvic US in Ovarian Cyst, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT02482467?

NCT02482467 is sponsored by University Hospital, Montpellier.

What drugs are being tested in NCT02482467?

Interventions in NCT02482467: Hormonal analysis, pelvic US.

What condition does NCT02482467 study?

NCT02482467 studies Ovarian Cyst.

Is NCT02482467 still recruiting?

NCT02482467 is currently terminated. Last updated 16 May 2025.

Last reviewed 2025-05-16 · How we verify

NCT02482467: KYSTOV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst

Terminated NA Last updated 16 May 2025

What this trial tests

NA trial testing Hormonal analysis, pelvic US in Ovarian Cyst in 105 participants. Terminated before completion.

Timeline

24 November 2014

Primary endpoint
29 March 2021

7 May 2025

Quick facts

Lead sponsor	University Hospital, Montpellier
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	105
Start date	24 November 2014
Primary completion	29 March 2021
Estimated completion	7 May 2025
Sites	1 location across France

Drugs / interventions tested

Hormonal analysis, pelvic US

Conditions studied

Ovarian Cyst — all drugs for Ovarian Cyst →

Sponsor

University Hospital, Montpellier

Who can join

Adults 6 to 24, female only, with Ovarian Cyst. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Puberty and long-term ovarian function of patients with a ovarian prenatal cyst has not described to date.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02482467 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 16 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02482467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing